Nj State Employees Deferred Compensation Plan Fibrogen Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Fibrogen Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 14,000 shares of FGEN stock, worth $4,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000
Previous 14,000
-0.0%
Holding current value
$4,340
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FGEN
# of Institutions
79Shares Held
37.4MCall Options Held
351KPut Options Held
105K-
Armistice Capital, LLC New York, NY6.8MShares$2.11 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$1.82 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA4.62MShares$1.43 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.21 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$746,9910.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $29.1M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...